HeartBeam ECG Registry
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- HeartBeam, Inc.
- Study ID
- NCT07501299
- Status
- Recruiting
Conditions
- Arrhythmia
- Atrial Fibrillation
- Atrial Flutter
- Bradycardia
- Tachycardia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Electrocardiogram (ECG) — DIAGNOSTIC_TESTThe intervention consists of non-invasive ECG recordings obtained using the HeartBeam System. Participants will use the device to capture cardiac electrical activity for assessment of heart rhythm, conduction patterns, and heart rate abnormalities in a clinical setting.
Study Details
The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.
Key Dates
- First listed
- Mar 30, 2026
- Start date
- Mar 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 600 participants (estimated)
Primary Outcome Measure
Creation of a de-identified ECG dataset for future research and regulatory use [ Time Frame: 2 years ]
Central Contacts
- Pooja Chatterjee408-899-4443
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | Joshua Silverstein, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By condition
By specialty
By research site
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPHASE3 · Recruiting · Johns Hopkins University · Phoenix, Arizona